Maria Dimou, Maria Karypidou, Aikaterini Bitsani, Marina Belia, Anastasia Kopsaftopoulou, Kalliopi Zerzi, Andreas Kiriakopoulos, Sotirios Sachanas, Ilias Pessach, Aikaterini Kolotsiou, Maria K Angelopoulou, Marina Siakantaris, Theodoros P Vassilakopoulos, Panayiotis Panayiotidis
{"title":"与阿卡拉布替尼耐药性相关的CLL患者BTK C515残基的新分离突变","authors":"Maria Dimou, Maria Karypidou, Aikaterini Bitsani, Marina Belia, Anastasia Kopsaftopoulou, Kalliopi Zerzi, Andreas Kiriakopoulos, Sotirios Sachanas, Ilias Pessach, Aikaterini Kolotsiou, Maria K Angelopoulou, Marina Siakantaris, Theodoros P Vassilakopoulos, Panayiotis Panayiotidis","doi":"10.1080/10428194.2025.2501269","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18047,"journal":{"name":"Leukemia & Lymphoma","volume":" ","pages":"1-3"},"PeriodicalIF":2.2000,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Novel isolated mutations at the C515 residue of BTK in a CLL patient associated with acalabrutinib resistance.\",\"authors\":\"Maria Dimou, Maria Karypidou, Aikaterini Bitsani, Marina Belia, Anastasia Kopsaftopoulou, Kalliopi Zerzi, Andreas Kiriakopoulos, Sotirios Sachanas, Ilias Pessach, Aikaterini Kolotsiou, Maria K Angelopoulou, Marina Siakantaris, Theodoros P Vassilakopoulos, Panayiotis Panayiotidis\",\"doi\":\"10.1080/10428194.2025.2501269\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":18047,\"journal\":{\"name\":\"Leukemia & Lymphoma\",\"volume\":\" \",\"pages\":\"1-3\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-05-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Leukemia & Lymphoma\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/10428194.2025.2501269\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leukemia & Lymphoma","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10428194.2025.2501269","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
期刊介绍:
Leukemia & Lymphoma in its fourth decade continues to provide an international forum for publication of high quality clinical, translational, and basic science research, and original observations relating to all aspects of hematological malignancies. The scope ranges from clinical and clinico-pathological investigations to fundamental research in disease biology, mechanisms of action of novel agents, development of combination chemotherapy, pharmacology and pharmacogenomics as well as ethics and epidemiology. Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor